Cargando…

Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.

A retrospective analysis was performed of 18 patients with primary malignant germ cell tumours of the mediastinum treated with platinum-based chemotherapy between 1977 and 1990. All seven patients with pure seminoma were treated initially with chemotherapy and four of these patients received additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Childs, W. J., Goldstraw, P., Nicholls, J. E., Dearnaley, D. P., Horwich, A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968447/
https://www.ncbi.nlm.nih.gov/pubmed/8494705
_version_ 1782134742101000192
author Childs, W. J.
Goldstraw, P.
Nicholls, J. E.
Dearnaley, D. P.
Horwich, A.
author_facet Childs, W. J.
Goldstraw, P.
Nicholls, J. E.
Dearnaley, D. P.
Horwich, A.
author_sort Childs, W. J.
collection PubMed
description A retrospective analysis was performed of 18 patients with primary malignant germ cell tumours of the mediastinum treated with platinum-based chemotherapy between 1977 and 1990. All seven patients with pure seminoma were treated initially with chemotherapy and four of these patients received additional mediastinal radiotherapy. Only one patient relapsed; his initial therapy had included radiotherapy and single-agent carboplatin and he was successfully salvaged with combination chemotherapy. With a follow-up of 11 to 117 months (median 41 months) all seven patients with seminoma remain alive and disease free giving an overall survival of 100%. Eleven patients had malignant non seminoma; following chemotherapy eight of these had elective surgical resection of residual mediastinal masses. Complete remission was achieved in nine (82%) patients, however, one of these patients died from bleomycin pneumonitis. With a follow-up of 12 to 113 months (median 55 months) eight of 11 (73%) patients with malignant mediastinal teratoma remain alive and disease free.
format Text
id pubmed-1968447
institution National Center for Biotechnology Information
language English
publishDate 1993
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19684472009-09-10 Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery. Childs, W. J. Goldstraw, P. Nicholls, J. E. Dearnaley, D. P. Horwich, A. Br J Cancer Research Article A retrospective analysis was performed of 18 patients with primary malignant germ cell tumours of the mediastinum treated with platinum-based chemotherapy between 1977 and 1990. All seven patients with pure seminoma were treated initially with chemotherapy and four of these patients received additional mediastinal radiotherapy. Only one patient relapsed; his initial therapy had included radiotherapy and single-agent carboplatin and he was successfully salvaged with combination chemotherapy. With a follow-up of 11 to 117 months (median 41 months) all seven patients with seminoma remain alive and disease free giving an overall survival of 100%. Eleven patients had malignant non seminoma; following chemotherapy eight of these had elective surgical resection of residual mediastinal masses. Complete remission was achieved in nine (82%) patients, however, one of these patients died from bleomycin pneumonitis. With a follow-up of 12 to 113 months (median 55 months) eight of 11 (73%) patients with malignant mediastinal teratoma remain alive and disease free. Nature Publishing Group 1993-05 /pmc/articles/PMC1968447/ /pubmed/8494705 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Childs, W. J.
Goldstraw, P.
Nicholls, J. E.
Dearnaley, D. P.
Horwich, A.
Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title_full Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title_fullStr Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title_full_unstemmed Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title_short Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
title_sort primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968447/
https://www.ncbi.nlm.nih.gov/pubmed/8494705
work_keys_str_mv AT childswj primarymalignantmediastinalgermcelltumoursimprovedprognosiswithplatinumbasedchemotherapyandsurgery
AT goldstrawp primarymalignantmediastinalgermcelltumoursimprovedprognosiswithplatinumbasedchemotherapyandsurgery
AT nichollsje primarymalignantmediastinalgermcelltumoursimprovedprognosiswithplatinumbasedchemotherapyandsurgery
AT dearnaleydp primarymalignantmediastinalgermcelltumoursimprovedprognosiswithplatinumbasedchemotherapyandsurgery
AT horwicha primarymalignantmediastinalgermcelltumoursimprovedprognosiswithplatinumbasedchemotherapyandsurgery